x

Posted 17 February, 2021

China Botanic Pharmaceutical appointed new CEO

CEO Change detected for ticker OTC:FBDS in a 8-K filed on 17 February, 2021.


  On February 4, 2021, Custodian appointed David Lazar as the Company's Chief Executive Officer, President, Secretary, Chief Financial Officer, Chief Executive Officer and Chairman of the Board of Directors.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of China Botanic Pharmaceutical
Health Care/Life Sciences • Pharmaceuticals
Fuss Brands Corp. engages in the research, manufacture and distribution of botanical products, bio-pharmaceutical products, and traditional Chinese medicines. Its products include Siberian ginseng, other plant-based anti-depression and nerve regulation products, botanical antibiotics, badger oil, and ginseng and deer antler extracts. The company was founded on August 18, 1988 and is headquartered in New York, NY.
Market Cap
N/A
View Company Details
China Botanic Pharmaceutical by TradingView
Relevant filing section
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. 


On February 4, 2021, Custodian appointed David Lazar as the Company's Chief Executive Officer, President, Secretary, Chief Financial Officer, Chief Executive Officer and Chairman of the Board of Directors.


David Lazar, 30, is a private investor. Mr. Lazar has been a partner at Zenith Partners International since 2013, where he specializes in research and development, sales and marketing. From 2014 through 2015. Since February of 2018, Mr. Lazar has been the managing member of Custodian Ventures LLC, where he specializes in assisting distressed public companies. Since March 2018, David has acted as the managing member of Activist Investing LLC, which specializes in active investing in distressed public companies. David has a diverse knowledge of financial, legal and operations management; public company management, accounting, audit preparation, due diligence reviews and SEC regulations.